Similar articles

Abstract: Objective: This study was designed to evaluate the association between skin autofluorescence (AF), an indicator of advanced glycation end-products (AGEs), and foot ulcers in subjects with diabetes. Methods: In this study, 195 Chinese diabetic subjects were examined. Their feet were examined regardless of whether an ulcer was present or not. Skin AF was measured with an AGE reader. Demographic characteristics and blood data were recorded. Results: The mean values of skin AF were 2.29±0.47 for subjects without foot ulcers, and 2.80±0.69 for those with foot ulcers, a significant difference (P<0.05). Skin AF was strongly correlated with age and duration of diabetes. After adjusting for these factors, multivariate logistic regression showed that skin AF was independently associated with foot ulcerations. Conclusions: Skin AF is independently associated with diabetic foot ulcerations. It might be a useful screening method for foot ulceration risk of diabetic patients.

[1]Apelqvist, J., Bakker, K., van Houtum, W.H., Schaper, N.C., 2008. Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) Prepared by the International Working Group on the Diabetic Foot. Diabetes Metab. Res. Rev., 24(S1):S181-S187.

[2]Boulton, A.J., Kirsner, R.S., Vileikyte, L., 2004. Clinical practice. Neuropathic diabetic foot ulcers. N. Engl. J. Med., 351(1):48-55.

[3]Brownlee, M., 2001. Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865):813-820.

[4]Chabroux, S., Canoui-Poitrine, F., Reffet, S., Mills-Joncour, G., Morelon, E., Colin, C., Thivolet, C., 2010. Advanced glycation end products assessed by skin autofluorescence in type 1 diabetics are associated with nephropathy, but not retinopathy. Diabetes Metab., 36(2):152-157.

[5]Dorrian, C.A., Cathcart, S., Clausen, J., Shapiro, D., Dominiczak, M.H., 1998. Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol. Biol. (Noisy-le-grand), 44(7):1069-1079.

[6]Dyer, D.G., Dunn, J.A., Thorpe, S.R., Bailie, K.E., Lyons, T.J., McCance, D.R., Baynes, J.W., 1993. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest., 91(6):2463-2469.

[7]Garrow, A.P., Boulton, A.J., 2006. Vibration perception threshold—a valuable assessment of neural dysfunction in people with diabetes. Diabetes Metab. Res. Rev., 22(5):411-419.

[8]Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R., Neil, H.A., 2008. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med., 359(15):1577-1589.

[9]Hoyt, R.E., 2004. Peripheral arterial disease in people with diabetes: response to consensus statement. Diabetes Care, 27(8):2095.

[10]Jeffcoate, W.J., Harding, K.G., 2003. Diabetic foot ulcers. Lance, 361(9368):1545-1551.

[11]Lapolla, A., Piarulli, F., Sartore, G., Ceriello, A., Ragazzi, E., Reitano, R., Baccarin, L., Laverda, B., Fedele, D., 2007. Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease. Diabetes Care, 30(3):670-676.

[12]Liu, Z., Fu, C., Wang, W., Xu, B., 2010. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients— a cross-sectional hospital based survey in urban China. Health Qual. Life Outcomes, 8(1):62.

[13]Meerwaldt, R., Graaff, R., Oomen, P.H., Links, T.P., Jager, J.J., Alderson, N.L., Thorpe, S.R., Baynes, J.W., Gans, R.O., Smit, A.J., 2004. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia, 47(7):1324-1330.

[14]Meerwaldt, R., Links, T.P., Graaff, R., Hoogenberg, K., Lefrandt, J.D., Baynes, J.W., Gans, R.O., Smit, A.J., 2005a. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia, 48(8):1637-1644.

[15]Meerwaldt, R., Hartog, J.W., Graaff, R., Huisman, R.J., Links, T.P., den Hollander, N.C., Thorpe, S.R., Baynes, J.W., Navis, G., Gans, R.O., et al., 2005b. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J. Am. Soc. Nephrol., 16(12):3687-3693.

[16]Meerwaldt, R., Lutgers, H.L., Links, T.P., Graaff, R., Baynes, J.W., Gans, R.O., Smit, A.J., 2007. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care, 30(1):107-112.

[17]Meerwaldt, R., van der Vaart, M.G., van Dam, G.M., Tio, R.A., Hillebrands, J.L., Smit, A.J., Zeebregts, C.J., 2008. Clinical relevance of advanced glycation endproducts for vascular surgery. Eur. J. Vasc. Endovasc. Surg., 36(2):125-131.

[18]Mišur, I., Žarkovic, K., Barada, A., Batelja, L., Miličević, Z., Turk, Z., 2004. Advanced glycation endproducts in peripheral nerve in type 2 diabetes with neuropathy. Acta Diabetol., 41(4):158-166.

[19]Monami, M., Lamanna, C., Gori, F., Bartalucci, F., Marchionni, N., Mannucci, E., 2008. Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res. Clin. Pract., 79(1):56-60.

[20]Peppa, M., Stavroulakis, P., Raptis, S.A., 2009. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair. Regen., 17(4):461-472.

[21]Prompers, L., Schaper, N., Apelqvist, J., Edmonds, M., Jude, E., Mauricio, D., Uccioli, L., Urbancic, V., Bakker, K., Holstein, P., et al., 2008. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia, 51(5):747-755.

[22]Vierron, E., Halimi, J.M., Giraudeau, B., 2010. Ankle-brachial index and peripheral arterial disease. N. Engl. J. Med., 362(5):471.